$MMM

3M CO

CIK:0000066740|SEC Filings
v3.25.4
Consolidated Statement of Income (Loss) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 24,948 $ 24,575 $ 24,610
Operating expenses      
Cost of sales 14,991 14,447 14,983
Selling, general and administrative expenses 3,997 4,221 19,198
Research, development and related expenses 1,169 1,085 1,154
Loss (gain) on business divestitures [1] 162 0 (36)
Total operating expenses 20,319 19,753 35,299
Operating income (loss) 4,629 4,822 (10,689)
Other expense (income), net 416 3 582
Income (loss) from continuing operations before income taxes 4,213 4,819 (11,271)
Provision (benefit) for income taxes 1,003 804 (2,867)
Income (loss) from continuing operations of consolidated group 3,210 4,015 (8,404)
Income from unconsolidated subsidiaries, net of taxes 52 9 18
Net income (loss) from continuing operations including noncontrolling interest 3,262 4,024 (8,386)
Less: net income attributable to noncontrolling interest 12 15 16
Net income (loss) from continuing operations attributable to 3M 3,250 4,009 (8,402)
Net income from discontinued operations, net of taxes 0 164 1,407
Net income (loss) attributable to 3M $ 3,250 $ 4,173 $ (6,995)
Earnings (loss) per share attributable to 3M common shareholders:      
Weighted average 3M common shares outstanding - basic (in shares) 537.4 550.8 553.9
Earnings (loss) per share from continuing operations — basic (in dollars per share) $ 6.05 $ 7.28 $ (15.17)
Earnings per share from discontinued operations — basic (in dollars per share) 0 0.30 2.54
Earnings (loss) per share — basic (in dollars per share) $ 6.05 $ 7.58 $ (12.63)
Weighted average 3M common shares outstanding - diluted (in shares) 541.3 552.4 553.9
Earnings (loss) per share from continuing operations — diluted (in dollars per share) $ 6.00 $ 7.26 $ (15.17)
Earnings per share from discontinued operations — diluted (in dollars per share) 0 0.29 2.54
Earnings (loss) per share — diluted (in dollars per share) $ 6.00 $ 7.55 $ (12.63)
[1] The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of discontinued operations in the 3M Consolidated Balance Sheet.